Devices › Catheter, flow directed
Device brand name · Continuous cardiac output catheter
Swan-Ganz Continuous Cardiac Output Catheter: medical device reports filed with FDA
208 reports name it, 2007–2009. Manufacturer given most often on reports: Edwards Lifesciences Pr. Product code DYG.
- 208
- device reports naming the brand
- 0% of all MAUDE reports · about 11 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 96.6%
- classified as malfunction
- 80.1% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
208 medical device reports received by FDA name the brand "Swan-Ganz Continuous Cardiac Output Catheter" (continuous cardiac output catheter); the manufacturer given most often on reports is Edwards Lifesciences Pr; received from July 2007 to August 2009. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (96.6%), other (1.9%) and injury (1.4%); across all catheter, flow directed reports (product code DYG) death is recorded in 2.9% and malfunction in 80.1%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are balloon leak(s) (26%), inflation problem (13.9%) and measurements, inaccurate (12.5%). The patient problems coded most often are bleeding, death and perforation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Swan-Ganz Continuous Cardiac Output Catheter was received in the five years to August 2026; the latest was received in August 2009.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 4,882 reports carrying product code DYG. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Balloon leak(s) | 54 | 26% | 2.9% |
| Inflation problem | 29 | 13.9% | 6.5% |
| Measurements, inaccurate | 26 | 12.5% | 2.2% |
| Fluid/blood leak | 20 | 9.6% | 2.9% |
| Deflation problem | 10 | 4.8% | 5.7% |
| Other (for use when an appropriate device code cannot be identified) | 9 | 4.3% | 1.6% |
| Air leak | 7 | 3.4% | 0.9% |
| Balloon rupture | 6 | 2.9% | 4.9% |
| Low readingsreadings were too low | 6 | 2.9% | 0.4% |
| Unable to obtain readings | 5 | 2.4% | 2.2% |
| Breakthe device broke | 4 | 1.9% | 3.8% |
| Difficult to removethe device was hard to remove | 4 | 1.9% | 2.4% |
| Incorrect measurementthe device measured wrongly | 4 | 1.9% | 4.4% |
| Crackthe device cracked | 3 | 1.4% | 0.5% |
| Hole in material | 3 | 1.4% | 0.4% |
| Cut in material | 2 | 1% | 0.8% |
| Deflation, cause unknown | 2 | 1% | 0.2% |
| Looping | 2 | 1% | 0.1% |
| Tip breakage | 2 | 1% | 0.3% |
| Material perforation | 1 | 0.5% | 0.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Bleeding | 1 | 0.5% |
| Deaththe patient died; cause not stated by this term | 1 | 0.5% |
| Perforation | 1 | 0.5% |
| Perforation of vessels | 1 | 0.5% |
| Surgical procedure | 1 | 0.5% |
| Tachycardiafast heart rate | 1 | 0.5% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Swan-Ganz Continuous Cardiac Output Catheter | Product code DYG | All MAUDE reports |
|---|---|---|---|
| Reports | 208 | 4,882 | 26,136,888 |
| Share of that pool | — | 4.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 29 | 9 |
| Classified as injury | 1.4% | 13.1% | 36.2% |
| Classified as malfunction | 96.6% | 80.1% | 62.3% |
| Filed by the manufacturer | 99.5% | 81.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code DYG
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Swan-Ganz catheter | 198 | 89 | 5.6% |
| Marathon Micro Catheter | 299 | 0 | 2.3% |
| Swan-Ganz Ccombo V | 165 | 88 | 0.6% |
| Swan-Ganz Bipolar Pacing Catheter For Femoral Insertion | 238 | 2 | 0.4% |
| Baxter | 821 | 3 | 3.8% |
| Swan-Ganz Bipolar Pacing Catheter For SVC Insertion | 310 | 14 | 0% |
| Attain | 459 | 0 | 1.5% |
| Abbott | 265 | 0 | 7.5% |
| Arrow | 830 | 65 | 3.4% |
| FloTrac Sensor | 194 | 10 | 0% |
| Apollo | 1,210 | 141 | 1.8% |
| Attain Command | 318 | 12 | 4.4% |
| Marathon | 506 | 66 | 5.9% |
| Catheter | 244 | 9 | 3.7% |
| Intra-Aortic Balloon Catheter | 433 | 0 | 3.9% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Swan-Ganz Continuous Cardiac Output Catheter reports
How many FDA reports name Swan-Ganz Continuous Cardiac Output Catheter?
208 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (96.6%), other (1.9%) and injury (1.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
balloon leak(s) (26%), inflation problem (13.9%), measurements, inaccurate (12.5%), fluid/blood leak (9.6%) and deflation problem (4.8%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.5%) and voluntary reports (0.5%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Swan-Ganz Continuous Cardiac Output Catheter was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.